Intervention Review

Oxcarbazepine versus phenytoin monotherapy for epilepsy

  1. Martie Muller1,*,
  2. Anthony G Marson2,
  3. Paula R Williamson3

Editorial Group: Cochrane Epilepsy Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 3 APR 2008

DOI: 10.1002/14651858.CD003615.pub2

Database Title

Additional Information

How to Cite

Muller M, Marson AG, Williamson PR. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003615. DOI: 10.1002/14651858.CD003615.pub2.

Author Information

  1. 1

    University of Copenhagen, Department of Life Sciences, Statistics Group, Copenhagen, Denmark

  2. 2

    Clinical Sciences Centre for Research & Education, University Department of Neurological Science, Liverpool, Merseyside, UK

  3. 3

    University of Liverpool, Centre for Medical Statistics and Health Evaluation, Liverpool, Merseyside, UK

*Martie Muller, Department of Life Sciences, Statistics Group, University of Copenhagen, Thorvaldsensvej 40, 1871 Frederiksberg C, Building: Højhus 73, Copenhagen, Denmark. martiemuller@idws.co.za. mmul@life.ku.dk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (60K)Standard (384K)Full (458K)

  1. Current Version

    Oxcarbazepine versus phenytoin monotherapy for epilepsy

    Martie Muller, Anthony G Marson and Paula R Williamson

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD003615.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Oxcarbazepine versus phenytoin monotherapy for epilepsy

    MM Muller, AG Marson and PR Williamson

    Article first published online: 25 JAN 2006 | DOI: 10.1002/14651858.CD003615

View Full Article (HTML) Summary (60K)Standard (384K)Full (458K)